| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |